MESQUITE, NV / ACCESSWIRE / December 10, 2019 / Cannabis Sativa, Inc. (CBDS) subsidiary PrestoDoctor, the leader in online cannabis evaluations serving over 100,000 patients across several states announces lower prices and earlier hours to allow med card access for all. “This is another major step in making quality medical cannabis care easier for those with a lower income. For PrestoDoctor, customized care isn’t changing – just the price. Lower prices and telemedicine means more patient access to our telemedicine platform and cannabis-friendly physicians”, COO & co-founder Rob Tankson said.

PrestoDoctor strives to improve the patient experience while always listening to the community. As a result, PrestoDoctor is lowering the prices of its telemedicine consultations in two states that have government application fees – to further expand patient’s access to our service.


  • If you are a non-resident looking for a California card, the price is $69.99.
  • If you are a resident looking for a Nevada card, the price is $89.99 for a 1-year card or $109.99 for a 2-year card. Note that the state charges a separate application fee ($50 for 1-year, $100 for 2-years).


  • The price is $109.99. Note that the state charges a separate application fee ($100, reduced to $20 if you have SoonerCare).

*Return Patient Renewals are still discounted

Earlier appointment times

Effective December 10, 2019, PrestoDoctor is excited to offer lower prices and earlier hours to better meet the needs of the patient’s schedules. The first appointment will now be offered at 9:00 am Eastern time, an hour earlier from the current start time of 10:00 am Eastern.

Savings with a Medical Cannabis Card

As a cannabis consumer, the cost benefits of having a medical card can be incredibly beneficial. In California, for example, for every $100 you spend, at least $20 goes towards taxes. Use our interactive calculator to learn how much you are spending on taxes for your adult-use cannabis purchase. A medical cannabis card helps ease some of the tax burdens for patients.

If you’re unsure if you qualify for a medical marijuana card, simply check the qualifying conditions:

Ready For a Medical Card?

PrestoDoctor’s sample life-size medical card

To get a medical cannabis card today, head over to PrestoDoctor and book an appointment. All PrestoDoctor appointments are done entirely online, allowing you to see one of our physicians from the comfort of your home couch, your work couch, or even a coffee shop couch!

There’s a reason PrestoDoctor has the highest customer satisfaction rating in the industry, and we are extremely excited to share that experience with more patients seeking cannabis for medicinal purposes.


About PrestoDoctor:

PrestoDoctor launched in California in the summer of 2015, and has since expanded into Nevada, New York, Oklahoma and Missouri. PrestoDoctor has facilitated over a hundred thousand appointments and maintains the highest customer satisfaction rating for any telemedicine service online. PrestoDoctor has over 4,000 5-star reviews, and is the first medical marijuana company to be accepted into the American Telemedicine Association. PrestoDoctor is HIPAA and HITECH compliant. PrestoDoctor plans to continue to expand its services in 2020.

About Cannabis Sativa, Inc.:

Cannabis Sativa, Inc. (“CBDS”) is engaged in the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS licenses the “hi” and “White Rabbit” brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (, Wild Earth Naturals® (, and iBudtender ( The Company is the official licensee for Virgin Mary Jane Brand ( In addition, CBDS seeks strategic partners for acquisition of operating companies, intellectual property and other assets which fit within the CBDS corporate vision.

Forward-Looking Statements:

This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact Information:

To inquire about purchasing or leasing CLICK HERE.

Corporate (702) 346-3906

Investor Relations
Mesquite, NV 89027

Spread the love